LADX

LadRx Corporation LADX

LADX
LadRx Corporation MRPI
Mera Pharmaceuticals, Inc. USRM
U.S. Stem Cell, Inc. DNAG
DNAPrint Genomics, Inc. MEDVF
Medivolve Inc. BIOIF
Biome Grow Inc. NNBP
Nanobac Pharmaceuticals, Incorporated INSD
Instadose Pharma Corp. MHTX
Manhattan Scientifics, Inc. NSPDF
Naturally Splendid Enterprises Ltd.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode LADX MRPI USRM DNAG MEDVF BIOIF NNBP INSD MHTX NSPDF
6M -92.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % 0.00 % -90.91 % 0.00 % 0.00 %
YTD -93.91 % 0.00 % 0.00 % 900.00 % -66.67 % -92.19 % 0.00 % -90.91 % -88.89 % 0.00 %
1Y -93.48 % 0.00 % 0.00 % 900.00 % -69.23 % -86.84 % 9 900.00 % -90.91 % -87.50 % 0.00 %
3Y -99.30 % 0.00 % -97.92 % 900.00 % -98.71 % -93.54 % 0.00 % -99.96 % -99.00 % 1 372.39 %
5Y -99.89 % -99.20 % -98.63 % -99.00 % 3 870.59 % -98.33 % -80.00 % -99.90 % -99.75 % 1 358.96 %
10Y -99.99 % -50.00 % -99.99 % -99.00 % 31 874.42 % -99.52 % 0.00 % -99.90 % -99.85 % 186.82 %
Depuis le début -100.00 % -99.90 % -100.00 % -100.00 % -99.97 % -99.67 % -100.00 % -99.90 % -100.00 % 143.90 %

Dividende

LadRx Corporation